News

Article

Evonik Qualifies Filling Line for Parenteral Drug Products at its Alabama Facility

The new line has the ability to aseptically fill powder, liquid, suspension, and combination forms into vials in clinical or commercial batch sizes.

Evonik, a contract development and manufacturing organization (CDMO) focused on drug delivery, announced on Sept. 9, 2020 that it has qualified its advanced aseptic filling line, VarioSys, for complex parenteral drug products at its Birmingham, AL, facility.

The new line has the ability to aseptically fill powder, liquid, suspension, and combination forms into vials in clinical or commercial batch sizes, a company press release said. The VarioSys line also features automated weight verification and interchangeable components and equipment to maintain the high-yield manufacturing of intricate filling processes.

The filling line can work in conjunction with highly potent, personalized or sensitive drug products and specialized vaccines formulated for systemic or localized delivery of small molecules, peptides, proteins, and nucleic acids, the press release said.

“The ability to cost-effectively fill complex parenteral drug products in powder and other forms within an aseptic environment has been a major unmet need for pharmaceutical companies,” said Paul Spencer, head of Pharma Polymers and Services at Evonik’s Health Care business line, in the press release. “The qualification of this advanced, modular filling line at our Birmingham facility will further enhance our ability to serve as a preferred partner to pharmaceutical customers during the formulation development and cGMP manufacturing of their polymeric and lipid-based parenteral drug products.”

Source: Evonik

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content